Show simple item record

dc.contributor.authorBerenguera, Anna
dc.contributor.authorPujol-Ribera, Enriqueta
dc.contributor.authorRodriguez-Blanco, Teresa
dc.contributor.authorViolan, Concepció
dc.contributor.authorCasajuana, Marc
dc.contributor.authorde Kort, Nelleke
dc.contributor.authorTrapero Bertran, Marta
dc.date.accessioned2019-12-05T09:48:19Z
dc.date.available2019-12-05T09:48:19Z
dc.date.issued2011-08-22
dc.identifier.citationBerenguera, Anna; Pujol-Ribera, Enriqueta; Rodriguez-Blanco, Teresa et al. «Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial». BMC Musculoskeletal Disorders, 2011, vol. 12, art. 194. Disponible en: <https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-12-194>. Fecha de acceso: 05 dic. 2019. DOI: 10.1186/1471-2474-12-194ca
dc.identifier.issn1471-2474ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/1374
dc.description.abstractBackground Low back pain (LBP), with high incidence and prevalence rate, is one of the most common reasons to consult the health system and is responsible for a significant amount of sick leave, leading to high health and social costs. The objective of the study is to assess the cost-effectiveness and cost-utility analysis of a multidisciplinary biopsychosocial educational group intervention (MBEGI) of non-specific sub-acute LBP in comparison with the usual care in the working population recruited in primary healthcare centres. Methods/design The study design is a cost-effectiveness and cost-utility analysis of a MBEGI in comparison with the usual care of non-specific sub-acute LBP. Measures on effectiveness and costs of both interventions will be obtained from a cluster randomised controlled clinical trial carried out in 38 Catalan primary health care centres, enrolling 932 patients between 18 and 65 years old with a diagnosis of non-specific sub-acute LBP. Effectiveness measures are: pharmaceutical treatments, work sick leave (% and duration in days), Roland Morris disability, McGill pain intensity, Fear Avoidance Beliefs (FAB) and Golberg Questionnaires. Utility measures will be calculated from the SF-12. The analysis will be performed from a social perspective. The temporal horizon is at 3 months (change to chronic LBP) and 12 months (evaluate the outcomes at long term). Assessment of outcomes will be blinded and will follow the intention-to-treat principle. Discussion We hope to demonstrate the cost-effectiveness and cost-utility of MBEGI, see an improvement in the patients' quality of life, achieve a reduction in the duration of episodes and the chronicity of non-specific low back pain, and be able to report a decrease in the social costs. If the intervention is cost-effectiveness and cost-utility, it could be applied to Primary Health Care Centres.ca
dc.format.extent9ca
dc.language.isoengca
dc.publisherBMCca
dc.relation.ispartofBMC Musculoskeletal Disordersca
dc.relation.ispartofseries12;194
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/ca
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherCost effectivenessca
dc.subject.otherCost-eficàciaca
dc.subject.otherAnálisis coste-beneficioca
dc.subject.otherEsquena--Malaltiesca
dc.subject.otherBack--Diseasesca
dc.subject.otherDorsalgiaca
dc.titleStudy protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trialca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/acceptedVersionca
dc.embargo.termscapca
dc.subject.udc33ca
dc.subject.udc61ca
dc.identifier.doihttps://doi.org/10.1186/1471-2474-12-194ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/